NEU 1.42% $15.26 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-48

  1. 13 Posts.
    lightbulb Created with Sketch. 20
    Some said "don't fall in love with the stock". I find this very hard to do with NEU with all that it has delivered so far.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.